These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9594332

  • 1. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
    Guo H, Lu G, Xiong X, Dong J, Liu S.
    Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332
    [Abstract] [Full Text] [Related]

  • 2. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 3. Intercellular transfer of P-glycoprotein from the drug resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact.
    Zhou HL, Zheng YJ, Cheng XZ, Lv YS, Gao R, Mao HP, Chen Q.
    J Urol; 2013 Sep; 190(3):1069-75. PubMed ID: 23618585
    [Abstract] [Full Text] [Related]

  • 4. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I, Sugiyama H, Kanazawa S, Hemmi H.
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [Abstract] [Full Text] [Related]

  • 5. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 6. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 7. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 8. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
    Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS.
    Cancer Res; 1996 Dec 01; 56(23):5435-42. PubMed ID: 8968098
    [Abstract] [Full Text] [Related]

  • 9. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
    Mirski SE, Gerlach JH, Cole SP.
    Cancer Res; 1987 May 15; 47(10):2594-8. PubMed ID: 2436751
    [Abstract] [Full Text] [Related]

  • 10. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov 15; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 11. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Nov 15; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 12. Medroxyprogesterone-acetate reverses the MDR phenotype of the CG5-doxorubicin resistant human breast cancer cell line.
    Zibera C, Gibelli N, Maestri L, Della Cuna GR.
    Anticancer Res; 1995 Nov 15; 15(3):745-9. PubMed ID: 7645952
    [Abstract] [Full Text] [Related]

  • 13. Development of doxorubicin resistant rat prostate cancer cell lines.
    Replogle-Schwab TS, Schwab ED, Pienta KJ.
    Anticancer Res; 1997 Nov 15; 17(6D):4535-8. PubMed ID: 9494564
    [Abstract] [Full Text] [Related]

  • 14. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.
    Kimiya K, Naito S, Soejima T, Sakamoto N, Kotoh S, Kumazawa J, Tsuruo T.
    J Urol; 1992 Aug 15; 148(2 Pt 1):441-5. PubMed ID: 1353119
    [Abstract] [Full Text] [Related]

  • 15. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
    Featherstone JM, Speers AG, Lwaleed BA, Hayes MC, Cooper AJ, Birch BR.
    BJU Int; 2005 May 15; 95(7):1091-8. PubMed ID: 15839939
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ, Bi H, Feng JQ, Cao JG.
    Acta Pharmacol Sin; 2005 Aug 15; 26(8):1009-16. PubMed ID: 16038636
    [Abstract] [Full Text] [Related]

  • 18. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
    Krishna CM, Kegelaer G, Adt I, Rubin S, Kartha VB, Manfait M, Sockalingum GD.
    Biopolymers; 2006 Aug 05; 82(5):462-70. PubMed ID: 16493658
    [Abstract] [Full Text] [Related]

  • 19. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I, Ohnoshi T, Hiraki S, Miyamoto H.
    Gan To Kagaku Ryoho; 1987 Mar 05; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [Abstract] [Full Text] [Related]

  • 20. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA, Nervi AM, Anthony SP, Kaltreider RC, Warren AJ, Pesce CA, Davis SA, Lariviere JP, Hamilton JW.
    Oncol Res; 1999 Mar 05; 11(7):303-10. PubMed ID: 10757444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.